Medicinal Plants as Anti-infectives

François Chassagne is a pharmacist and researcher at the IRD (French National Research Institute for Sustainable Development) in the UMR 152 PharmaDev research unit based in Toulouse, France. He graduated from the School of Pharmacy at Paris Descartes University in France, and he obtained his Ph.D. degree in Pharmacology at the Paul Sabatier University in Toulouse, France. He was a postdoctoral fellow specializing in the study of anti-infective medicinal plants at Emory University in Atlanta, GA in the United States. He is currently working in the field of ethnopharmacology, developing ethnobotanical and pharmacological tools to validate the use of traditional remedies.

1. A review of medicinal plants used as antimicrobials in Colombia
2. Plants used in Lebanon and the Middle East as antimicrobials
3. Medicinal plants in the Balkans with antimicrobial properties
4. Medicinal plants used in South Africa as antibacterial agents for wound healing
5. The use of South African medicinal plants in the pursuit to treat gonorrhea and other sexually transmitted diseases
6. A selection of antibacterial medicinal plants from Pakistan
7. Medicinal plants used as anti-diarrheal agents in the lower Mekong basin
8. Medicinal plants from West Africa used as antimalarial agents: an overview
9. Mycobacterium quorum quenching and biofilm inhibition potential of medicinal plants
10. Untargeted metabolomics for the study of anti-infective plants
11. Value chains and DNA barcoding for the identification of anti-infective medicinal plants
12. Fungal endophytes: a source of antibacterial and antiparasitic compounds
13. Antiviral potential of medicinal plants: a case-study with guava tree against dengue virus using a metabolomic approach
14. How History Can Help Present Research of New Antimicrobial Strategies: The Case of Cutaneous Infections Remedies Containing Metals From The Middle Age Arabic Pharmacopeia
15. Improved traditional medicine for infectious disorders in Mali
16. Selecting the most promising local treatments. Retrospective treatment outcome surveys and reverse pharmacology
17. Nagoya Protocols and ABS: basic concepts